HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Private-Equity Investors Poised To Acquire Nestlé Skin Health, Promising US Expansion

Executive Summary

After working hard to turnaround its troubled Skin Health dermatology operation, Nestlé looks set to offload the business to a consortium of private-equity buyers. The consortium - led by EQT - have identified expansion in the US consumer health market as an immediate priority.

You may also be interested in...



Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment

Nestle agrees to acquire Aimmune Therapeutics, maker of a drug indicated to reduce the severity of children’s allergic reactions to peanuts. It anticipates options to innovate in its consumer health children’s allergy business.

EU Business Round-Up: Galderma Divests To Dallman’s, Oysershell names CEO, Ceres Acquires

Latest business news in the EU: Galderma offloads German Bübchen brand to Dallman's; Belgium's Oystershell names experienced CEO; Ceres Pharma snaps up Romania's Viva.

Nestlé Skin Health Has Suitors ‘Lining Up Around The Block’ After ‘Stunning’ Sales Turnaround

Nestlé's once troubled Skin Health business is now a "leader in its space" after an astonishing turnaround, according to the Swiss firm's CEO. What's more, potential buyers for the unit are queuing out the door, waiting for Nestlé to kick off a much anticipated sale process.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS148823

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel